Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROPHAMET
2024-515434-32-00Phase 2Authorised
- Sponsor
- Hospices Civils de Lyon
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of avelumab and methotrexate in trophoblastic tumour, sponsored by Hospices Civils de Lyon. Planned start Aug 2024; status: authorised.
02
Drugs
avelumabmethotrexate
03
Conditions
trophoblastic tumour
Beyond the preview
Go deeper on 2024-515434-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515434-32-00.